Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Capecitabine for Sale > Capecitabine CAS 154361-50-9 good quality safe fast delivery
Capecitabine CAS 154361-50-9 good quality safe fast delivery buy - large image1
Capecitabine CAS 154361-50-9 good quality safe fast delivery buy - image1
Capecitabine CAS 154361-50-9 good quality safe fast delivery buy - image2
Capecitabine CAS 154361-50-9 good quality safe fast delivery buy - image3
Capecitabine CAS 154361-50-9 good quality safe fast delivery buy - image4

Capecitabine CAS 154361-50-9 good quality safe fast delivery

9 Inquiries

Unit Price: Get Latest Price
CAS No.:

154361-50-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

/

Brand:

Million

Packaging:

cardboard drum

Sample Available:

Yes

Price valid (until):

2024-11-24

Company Type:
Manufactory
Location:
China
Payment Terms:
L/C,100% TT in advance
Average Lead Time:
3 days
Qualification:
Main Products:

Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Shop Apixaban CAS 503612-47-3 FACTORY supply-Detailed Image 1

    -Product Descrition-

    General: Capecitabine is an antimetabolite fluoropyrimidine deoxynucleoside carbamate that can be converted to 5-FU in vivo. It is used as an anticancer drug, mainly for non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

    Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 2


    Why Choose Us ?

    1 、  Manufacturer supply, best price and service.

    2、  Safe fast delivery.

    3、  F   ree sample.

    4、 Large stock.

    5、  Easy payment: bank transfer,  moneygram, paypal....

    6、  Good reputation, great feedback.

    7、  Customers worldwide:   Metrochem Api Pvt Ltd;Bdr Lifesciences Pvt.Ltd;Srini Chem;Eva Pharma;Pharmaffiliates Analytics&Synthetics(p)Ltd;....From India,Egypt,Canada ....


    -Packing&Shipping-

    Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 3


    Ship methods

    Special line

    Express

    By air

    By sea

    DHL/TNT/FeDex/UPS

    Delivery

    7-15 days

    3-10 days

    3-5 days

    10-30 days

    Service

    Door to door

    Door to door

    To airport

    To seaport

    Customs clearance

    No

    Possible

    Yes

    Yes


    -Company Profile-

    Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 4

    Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 5


    About us:

    Founded in 2012, Jinan Million Pharmaceutical Co., Ltd (Jinan Milin Pharmaceutical Co., Ltd) is a modern pharmaceutical enterprise guided by innovation. Million pharm has excellent research and development capabilities and complete industrial bases with international quality management system. It is dedicated to the research, development, production and customization of pharmaceuticals and advanced pharmaceutical intermediates.
     
       Jinan Million Pharmaceutical Co., Ltd has been focusing on the research of Cerebro-cardiovascular drugs, Central nervous system drugs, Anti-cancer drugs, Antibacterial drugs and others for 12 years; the products are: Apixab  a  n, Lurasidon  e  , Bexagliflozin, Vortioxetine, L  OXO  -292/Selpercatinib, Baricitinib and intermediates. Million has worked with reputable customers, like METROCHEM API PVT LTD; BDR LIFESCIENCES PVT.LTD; SRINI CHEM; EVA PHARMA; PHARMAFFILIATES ANALYTICS & SYNTHETICS (P) LTD; ....from India, Egypt, Canada...


    Jinan Million Pharmaceutical Co., Ltd has a 1,500㎡ R&D center in the Zhongguancun E Valley (Qihe) Incubator, equipped with complete test equipment, such as high-performance liquid chromatography, nuclear magnetic resonance spectrometer, liquid chromatography mass spectrometer, automatic polarimeter, etc., which can meet the needs of various  laboratory scale tests in different conditions. The pilot workshop is equipped with 50L and 100L glass reactors, high and low temperature equipment, etc., which can support organic chemical reactions at -100°C or 200°C. In addition, Million has a production site in Linyi city with many independent production lines, such as: production line of Apixabn intermediate 20 tons/year, production line of Lurasidon intermediate 10 tons/year, which can meet the commercial production of various products.
     
       The technical team is composed of high-level talents in major of pharmacy, bio-pharmaceutical or chemical synthesis, of which 10% has doctor’s degree and 15% has master’s degree. The team members are young and energetic with innovative spirit and willing to overcome obstacles.
     
       Jinan Million Pharmaceutical Co., Ltd adheres to the business philosophy of "dedication and innovation", insists on pioneering and innovating, constantly improves the quality system, and vigorously trains technical and management talents to build an elite team and serves customers better. Looking forward to cooperate with you for joint development and common progress.


    -Certification- Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 6


    ECHEMI Editorial Reference
    Colourless solidCapecitabine is a new oral fluoropyrimidine carbamate for patients with advanced neoplastic disease, approved as Xeloda for the treatment of refractory metastatic breast cancer after failure on Paclitaxel and an anthracycline-based chemotherapy regimen ; it is a prodrug of doxifluridine (5-fluorouracil ; 5-FU) activated by a cascade of 3 enzymes concentrated in human liver and cancer tissue, resulting in the selective release of 5-FU at the tumor site and offering a prolo
    Solid
    Capecitabine is a carbamate ester that is cytidine in which the hydrogen at position 5 is replaced by fluorine and in which the amino group attached to position 4 is converted into its N-(penyloxy)carbonyl derivative. Capecitabine is a antineoplastic agent used in the treatment of cancers. It has a role as an antineoplastic agent, a prodrug and an antimetabolite. It is a carbamate ester, an organofluorine compound and a member of cytidines.|Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.|Capecitabine is a Nucleoside Metabolic Inhibitor. The mechanism of action of capecitabine is as a Nucleic Acid Synthesis Inhibitor.|Capecitabine is a pyrimidine analogue used as an antineoplastic agent to treat metastatic and advanced forms of breast and colon cancer, often in combination with other agents. Capecitabine is associated with a low rate of transient serum aminotransferase elevations during therapy but has been only rarely implicated in cases of clinically apparent acute liver injury.|Capecitabine is a fluoropyrimidine carbamate belonging to the class of antineoplastic agents called antimetabolites. As a prodrug, capecitabine is selectively activated by tumor cells to its cytotoxic moiety, 5-fluorouracil (5-FU); subsequently, 5-FU is metabolized to two active metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP) by both tumor cells and normal cells. FdUMP inhibits DNA synthesis and cell division by reducing normal thymidine production, while FUTP inhibits RNA and protein synthesis by competing with uridine triphosphate for incorporation into the RNA strand. (NCI04)|A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.

    Basic Info
    Product Name:

    Capecitabine

    Other Name:

    Cytidine,5′-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-;Carbamic acid,[1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-,pentyl ester;5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;Ro 09-1978/000;Capecitabine;Ro 09-1978;5′-Deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine;Xeloda;Capecitibine;Capecytabine;Capiibine;Captabin;N4-Pentyloxycarbonyl-5′-deoxy-5-fluorocytidine;Capacetrine;Ecansya;Capecitabine Medac;Capecitabine Accord;Capecitabine Teva;Capecitabine SUN;Xeltabin;158798-73-3;958887-39-3

    CAS No.:

    154361-50-9

    Molecular Formula:

    C15H22FN3O6

    InChIKeys:

    InChIKey=GAGWJHPBXLXJQN-UORFTKCHSA-N

    Molecular Weight:

    359.35000

    Exact Mass:

    359.35

    UNII:

    6804DJ8Z9U

    DSSTox ID:

    DTXSID3046451

    NCI Thesaurus Code:

    C1794

    Color/Form:

    White to off-white crystalline powder|Crystals from ethyl acetate

    ATC Code:

    L01BC06|L - Antineoplastic and immunomodulating agents

    HScode:

    2934999090

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    122.91000

    XLogP3:

    0.6

    Appearance:

    white to beige

    Density:

    1.49 g/cm3

    Melting Point:

    88-89 °C

    Boiling Point:

    437.874ºC at 760 mmHg

    Flash Point:

    218.619ºC

    Refractive Index:

    1.7

    Water Solubility:

    2.48e-01 g/L

    Storage Conditions:

    Store in original container in a cool dark place.

    Vapor Pressure:

    0mmHg at 25°C

    Henrys Law Constant:

    Henry's Law constant = 2.9X10-19 atm-cu m/mol at 25 °C (est)

    Dissociation Constants:

    pKa1 = 1.9 (amide)

    Experimental Properties:

    Hydroxyl radical reaction rate constant = 8.27X10-11 cu cm/molec-sec at 25 °C (est)|Ozone reaction rate constant = 7.0X10-15 cu cm/molec-sec at 25 °C (est)

    Hazard Identification

    Classification of the substance or mixture

    Germ cell mutagenicity, Category 2

    Carcinogenicity, Category 1B

    Reproductive toxicity, Category 1B

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H341 Suspected of causing genetic defects

    H350 May cause cancer

    H360 May damage fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

    Location:

    Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China

    Payment Terms:

    L/C,100% TT in advance

    Average lead Time:

    3 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2012

    Company Certificates
    • Jinan Million Pharmaceutical Co., Ltdbusiness license business license

    Founded in 2012, Jinan Million Pharmaceutical Co., Ltd (Jinan Milin Pharmaceutical Co., Ltd) is a modern pharmaceutical enterprise guided by innovation. Million pharm has excellent research and development capabilities and complete industrial bases with international quality management system. It is dedicated to the research, development, production and customization of pharmaceuticals and advanced pharmaceutical intermediates.
     
    Jinan Million Pharmaceutical Co., Ltd has been focusing on the research of Cerebro-cardiovascular drugs, Central nervous system drugs, Anti-cancer drugs, Antibacterial drugs and others for 12 years; the products are: Apixaban, Lurasidone, Bexagliflozin, Votioxitine, Loxo-292/Selpercatinib, Baricitinib and intermediates. Million has worked with reputable customers, like METROCHEM API PVT LTD; BDR LIFESCIENCES PVT.LTD; INCETPAT PHARM; SRINI CHEM; EVA PHARMA; PHARMAFFILIATES ANALYTICS & SYNTHETICS (P) LTD; ....from India, Egypt, Canada...



    Jinan Million Pharmaceutical Co., Ltd has a 1,500㎡ R&D center in the Zhongguancun E Valley (Qihe) Incubator, equipped with complete test equipment, such as high-performance liquid chromatography, nuclear magnetic resonance spectrometer, liquid chromatography mass spectrometer, automatic polarimeter, etc., which can meet the needs of various  laboratory scale tests in different conditions. The pilot workshop is equipped with 50L and 100L glass reactors, high and low temperature equipment, etc., which can support organic chemical reactions at -100°C or 200°C. In addition, Million has a production site in Linyi city with many independent production lines, such as: production line of Apixabn intermediate 20 tons/year, production line of Lurasidon intermediate 10 tons/year, which can meet the commercial production of various products.
     
    The technical team is composed of high-level talents in major of pharmacy, bio-pharmaceutical or chemical synthesis, of which 10% has doctor’s degree and 15% has master’s degree. The team members are young and energetic with innovative spirit and willing to overcome obstacles.
     
    Jinan Million Pharmaceutical Co., Ltd adheres to the business philosophy of "dedication and innovation", insists on pioneering and innovating, constantly improves the quality system, and vigorously trains technical and management talents to build an elite team and serves customers better. Looking forward to cooperate with you for joint development and common progress.

  • Inquiry History
    9 Inquiries
    Country Product Purchase Quantity Date Posted
    United Arab Emirates

    Capecitabine

    150.00 KG Jul 23, 2024
    India

    Capecitabine

    1 G Aug 28, 2026
    Turkey

    Capecitabine

    100 KG Oct 21, 2025
    Japan

    Capecitabine(GMP+CEP)

    100 G May 13, 2024
    India

    Capecitabine

    60 KG Sep 17, 2026
    Democratic Republic of the Congo

    Capecitabine

    1 MT Dec 8, 2025
    Turkey

    Capcetabine

    100 KG Nov 27, 2025
    Pakistan

    Capecitabine

    1 KG Sep 26, 2025
    Spain

    Capecitabine

    500 MG Oct 23, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.